<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>114(5)</volume><submitter>Bonnet G</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Systems of care have been challenged to control progression of the COVID-19 pandemic. Whether this has been associated with delayed reperfusion and worse outcomes in French patients with ST-segment elevation myocardial infarction (STEMI) is unknown.&lt;h4>Aim&lt;/h4>To compare the rate of STEMI admissions, treatment delays, and outcomes between the first peak of the COVID-19 pandemic in France and the equivalent period in 2019.&lt;h4>Methods&lt;/h4>In this nationwide French survey, data from consecutive STEMI patients from 65 centres referred for urgent revascularization between 1 March and 31 May 2020, and between 1 March and 31 May 2019, were analysed. The primary outcome was a composite of in-hospital death or non-fatal mechanical complications of acute myocardial infarction.&lt;h4></pubmed_abstract><journal>Archives of cardiovascular diseases</journal><pagination>340-351</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9056233</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France.</pubmed_title><pmcid>PMC9056233</pmcid><pubmed_authors>MODIF registry investigators</pubmed_authors><pubmed_authors>Bouisset F</pubmed_authors><pubmed_authors>Becker M</pubmed_authors><pubmed_authors>Bonello L</pubmed_authors><pubmed_authors>Duband B</pubmed_authors><pubmed_authors>Meneveau N</pubmed_authors><pubmed_authors>Lattuca B</pubmed_authors><pubmed_authors>Noirclerc N</pubmed_authors><pubmed_authors>Motreff P</pubmed_authors><pubmed_authors>Robin M</pubmed_authors><pubmed_authors>Zeitouni M</pubmed_authors><pubmed_authors>Juenin L</pubmed_authors><pubmed_authors>Semaan C</pubmed_authors><pubmed_authors>Martin AS</pubmed_authors><pubmed_authors>Isaaz K</pubmed_authors><pubmed_authors>Tirouvanziam A</pubmed_authors><pubmed_authors>Adjedj J</pubmed_authors><pubmed_authors>Uhry S</pubmed_authors><pubmed_authors>Boukantar M</pubmed_authors><pubmed_authors>Pansieri M</pubmed_authors><pubmed_authors>Bonnet G</pubmed_authors><pubmed_authors>Belle L</pubmed_authors><pubmed_authors>Kerneis M</pubmed_authors><pubmed_authors>Vignac M</pubmed_authors><pubmed_authors>Van Belle E</pubmed_authors><pubmed_authors>Chamandi C</pubmed_authors><pubmed_authors>Panagides V</pubmed_authors><pubmed_authors>Moussa K</pubmed_authors><pubmed_authors>Palermo V</pubmed_authors><pubmed_authors>Angoulvant D</pubmed_authors><pubmed_authors>Riviere N</pubmed_authors><pubmed_authors>Yvorel C</pubmed_authors><pubmed_authors>Khalife K</pubmed_authors><pubmed_authors>Vincent F</pubmed_authors><pubmed_authors>Benamer H</pubmed_authors><pubmed_authors>Cetran L</pubmed_authors><pubmed_authors>Lesizza P</pubmed_authors><pubmed_authors>Cayla G</pubmed_authors><pubmed_authors>Manchuelle A</pubmed_authors><pubmed_authors>Pamart T</pubmed_authors><pubmed_authors>Deney A</pubmed_authors><pubmed_authors>De Poli F</pubmed_authors></additional><is_claimable>false</is_claimable><name>ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France.</name><description>&lt;h4>Background&lt;/h4>Systems of care have been challenged to control progression of the COVID-19 pandemic. Whether this has been associated with delayed reperfusion and worse outcomes in French patients with ST-segment elevation myocardial infarction (STEMI) is unknown.&lt;h4>Aim&lt;/h4>To compare the rate of STEMI admissions, treatment delays, and outcomes between the first peak of the COVID-19 pandemic in France and the equivalent period in 2019.&lt;h4>Methods&lt;/h4>In this nationwide French survey, data from consecutive STEMI patients from 65 centres referred for urgent revascularization between 1 March and 31 May 2020, and between 1 March and 31 May 2019, were analysed. The primary outcome was a composite of in-hospital death or non-fatal mechanical complications of acute myocardial infarction.&lt;h4></description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2026-05-31T01:07:31.461Z</modification><creation>2025-04-04T11:31:33.934Z</creation></dates><accession>S-EPMC9056233</accession><cross_references><pubmed>33926830</pubmed><doi>10.1016/j.acvd.2021.01.005</doi></cross_references></HashMap>